• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Eyeonics clarifies lens will treat presbyopia

Article

Aliso Viejo, CA-Eyeonics Inc. is altering the wording of the physician's labeling on its Crystalens IOL to indicate better that it can treat presbyopia.

Aliso Viejo, CA-Eyeonics Inc. is altering the wording of the physician's labeling on its Crystalens IOL to indicate better that it can treat presbyopia.

The wording previously did not specify that patients with presbyopia would benefit, but a number of clinical Web sites have included that in their explanations of the lens and refractive lensectomy.

The new label indicates that the Crystalens is intended for primary implantation in the capsular bag for the correction of aphakia "secondary to the removal of a cataractous lens in adult patients with and without presbyopia."

"Prospective patients will realize that they are going to receive a new technologically advanced lens that replaces their dysfunctional natural lens as well as providing them a viable option to restore their continuous range of vision that they enjoyed earlier in life," he said.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.